T2D Management: Advancements, Research, and Outlook
Received Date: Jun 02, 2025 / Published Date: Jun 30, 2025
Abstract
This compilation reviews Type 2 Diabetes, detailing advancements in pharmacological treatments, including GLP-1 receptor agonists and SGLT2 inhibitors, noting their efficacy in glycemic control and cardiovascular outcomes. It explores the disease’s pathophysiology, emerging therapeutic targets, and the impact of gut microbiota. The data also highlights the importance of precision medicine, addresses the severe microvascular and macrovascular complications, and discusses the global burden of diabetes, along with the efficacy of metabolic surgery. Overall, it provides a comprehensive overview of current and future strategies for T2D prevention and management.
Citation: Johnson M (2025) T2D Management: Advancements, Research, and Outlook. jowt 15: 817.
Copyright: 漏 2025 Michael Johnson This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 465
- [From(publication date): 0-0 - Apr 07, 2026]
- Breakdown by view type
- HTML page views: 339
- PDF downloads: 126
